{"transactions":[{"id":1147202,"issuer":{"id":79750,"kind":"organization","name":"Unique Logistics International, Inc.","symbol":"UNQL"},"owners":[{"id":79751,"kind":"person","name":"Briones David S.","position":1,"cik":"0001599831","reported_name":"Briones David S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2025-05-15T10:26:45.000Z","date":"2025-05-14","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":20000,"price":35.8055,"value":716110.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger by and among Unique Logistics International, Inc., (\"UNQL\"), DP World Logistics US Holdings, Inc. (\"Parent\"), and Unique Merger Co., a wholly owned subsidiary of Parent, dated March 11, 2025, Unique Merger Co. merged with and into UNQL, with UNQL surviving as a wholly owned subsidiary of Parent. At the effective time of the merger, each share of Series A Convertible Preferred Stock converted into the right to receive a lump-sum cash payment equal to $0.0037 per share of Common Stock, multiplied by 9,677.1581, the number of shares of Common Stock issuable upon conversion of each Series A share pursuant to its Certificate of Designation, including applicable anti-dilution provisions."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001641172-25-010601","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281845/000164117225010601/ownership.xml","form_type":"4"}},{"id":2339325,"issuer":{"id":8639,"kind":"organization","name":"ZyVersa Therapeutics, Inc."},"owners":[{"id":79751,"kind":"person","name":"Briones David S.","position":1,"cik":"0001599831","reported_name":"Briones David S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class B common stock","published_at":"2022-03-10T17:30:21.000Z","date":"2022-01-06","kind":"other","acquired":true,"shares":91,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"see footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the \"Registration Statement\") under the section entitled \"Description of Securities - Founder Shares,\" the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date"},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the \"Registration Statement\") under the section entitled \"Description of Securities - Founder Shares,\" the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date"},{"field":"kind","element":"transactionCoding","label":"F3","text":"As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the \"Registration Statement\") under the section entitled \"Description of Securities - Founder Shares,\" the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date"},{"field":"shares","element":"transactionShares","label":"F5","text":"In connection with the partial exercise of the underwriters' over-allotment option, A.G.P./Alliance Global Partners transferred 3,427 shares to the Sponsor for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the \"Registration Statement\") under the section entitled \"Description of Securities - Founder Shares,\" the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the \"Registration Statement\") under the section entitled \"Description of Securities - Founder Shares,\" the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date"},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The shares represent those owned by Mr. Briones, a member of Larkspur Health LLC based on his pro rata share of ownership of Larkspur Health LLC."}],"balance_after":56123,"derivative":{"underlying":"Class A common stock","underlying_shares":156},"source":{"system":"sec-edgar","filing":"0001213900-22-011641","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1599831/000121390022011641/ownership.xml","form_type":"4"}},{"id":2339324,"issuer":{"id":8639,"kind":"organization","name":"ZyVersa Therapeutics, Inc."},"owners":[{"id":79751,"kind":"person","name":"Briones David S.","position":1,"cik":"0001599831","reported_name":"Briones David S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class B common stock","published_at":"2022-03-10T17:30:21.000Z","date":"2022-01-06","kind":"other","acquired":false,"shares":1533,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"see footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the \"Registration Statement\") under the section entitled \"Description of Securities - Founder Shares,\" the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date"},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the \"Registration Statement\") under the section entitled \"Description of Securities - Founder Shares,\" the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date"},{"field":"kind","element":"transactionCoding","label":"F3","text":"As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the \"Registration Statement\") under the section entitled \"Description of Securities - Founder Shares,\" the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date"},{"field":"shares","element":"transactionShares","label":"F4","text":"As contemplated in connection with the initial public offering of the Issuer, 22,343 shares of Class B common stock of the Issuer were forfeited for no consideration and cancelled because the underwriters of the Issuer's initial public offering did not exercise their over-allotment option in full, as described in the Issuer's Registration Statement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the \"Registration Statement\") under the section entitled \"Description of Securities - Founder Shares,\" the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the \"Registration Statement\") under the section entitled \"Description of Securities - Founder Shares,\" the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date"},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The shares represent those owned by Mr. Briones, a member of Larkspur Health LLC based on his pro rata share of ownership of Larkspur Health LLC."}],"balance_after":55967,"derivative":{"underlying":"Class A common stock","underlying_shares":1533},"source":{"system":"sec-edgar","filing":"0001213900-22-011641","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1599831/000121390022011641/ownership.xml","form_type":"4"}},{"id":2339323,"issuer":{"id":8639,"kind":"organization","name":"ZyVersa Therapeutics, Inc."},"owners":[{"id":79751,"kind":"person","name":"Briones David S.","position":1,"cik":"0001599831","reported_name":"Briones David S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2022-03-10T17:30:21.000Z","date":"2022-01-06","kind":"other","acquired":true,"shares":10752,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"see footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These shares are underlying units (each unit consisting of one share of Class A common stock and three-fourths of one warrant, each whole warrant exercisable to purchase one share of Class A common stock) acquired in a private placement by the Larkspur Health LLC (the \"Sponsor\") in connection with the issuer's initial public offering and subsequent partial exercise of the underwriters' over-allotment option. The above refers to the shares of Class A common stock included in the units purchased."},{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares are underlying units (each unit consisting of one share of Class A common stock and three-fourths of one warrant, each whole warrant exercisable to purchase one share of Class A common stock) acquired in a private placement by the Larkspur Health LLC (the \"Sponsor\") in connection with the issuer's initial public offering and subsequent partial exercise of the underwriters' over-allotment option. The above refers to the shares of Class A common stock included in the units purchased."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares represent those owned by Mr. Briones, a member of Larkspur Health LLC based on his pro rata share of ownership of Larkspur Health LLC."}],"balance_after":10752,"source":{"system":"sec-edgar","filing":"0001213900-22-011641","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1599831/000121390022011641/ownership.xml","form_type":"4"}},{"id":3605771,"issuer":{"id":7736,"kind":"organization","name":"Rocket One Inc."},"owners":[{"id":79751,"kind":"person","name":"Briones David S.","position":1,"cik":"0001599831","reported_name":"Briones David S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Options","published_at":"2019-03-07T16:33:21.000Z","date":"2019-03-06","kind":"other","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The options were issued pursuant to the Issuer's 2018 Equity Incentive Plan and vested in full upon grant."}],"balance_after":50000,"derivative":{"exercise_price":5.88,"exercise_date":"2019-03-06","expiration_date":"2024-03-06","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001213900-19-003749","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1599831/000121390019003749/ownership.xml","form_type":"4"}}]}